Lykan Bioscience
His entrepreneurial career started in 1982, founding a number of companies in Public Relations, Technology, Advertising, and Music & Personality management backed by The Abingdon Management Company Limited, where he subsequently became sole owner having acquired Abingdon from its institutional shareholders. Abingdon had a number of quoted and unquoted investments including a Unit Trust, Foretronic (a technology company that introduced the magnetic data strip on the back of credit cards), TVS (ITV franchise for the South of England), and a significant property portfolio in the UK and abroad.
Returning to his medical roots, Geoffrey developed and guided Oncimmune, a company pioneering technologies to enable early cancer detection, from a Nottingham University start-up through to a successful IPO in May 2016, with total funds raised of £62m. During this period he co-authored numerous scientific and health economic publications.
He now acts as an advisor to leading technology and healthcare funds, advising investment teams, and specific due diligence projects, monitoring investments as a director, and mentoring CEOs.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Lykan Bioscience
Lykan combines decades of industry experience with a drive to save lives. Lykan's goal is to provide the first true end-to-end solution in cell and gene manufacturing; ushering in a new era in the industry.